Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens.
C BuscaM Sánchez-CondeM RicoM RosasE ValenciaA MorenoV MorenoL Martín-CarboneroS MorenoJosé Ignacio Bernardino SernaJ I BernardinoJ R ArribasJ GonzálezA OlveiraP CastilloM AbadíaL GuerraC MendezMaría Luisa García MontesPublished in: Open forum infectious diseases (2022)
Ultrasound and CAP performed best in diagnosing liver steatosis, and FLI, TyG, and HSI performed well. We propose an easy-to-implement algorithm with TyG or FLI as the first test and ultrasound or CAP as the second test to accurately diagnose or exclude NAFLD.
Keyphrases
- human immunodeficiency virus
- liver fibrosis
- hepatitis c virus
- end stage renal disease
- antiretroviral therapy
- hiv infected
- insulin resistance
- magnetic resonance imaging
- hiv aids
- ejection fraction
- high fat diet
- chronic kidney disease
- newly diagnosed
- hiv positive
- prognostic factors
- peritoneal dialysis
- deep learning
- machine learning
- ultrasound guided
- high fat diet induced
- patient reported outcomes
- skeletal muscle
- neural network
- metabolic syndrome